Correlation between cognitive impairment and cerebral hemodynamic disturbances on perfusion magnetic resonance imaging in European adults with moyamoya disease

Clinical article

Restricted access

Object

Although cognitive impairment has been reported in adults with moyamoya disease (MMD), its relationship with cerebral hemodynamic disturbances has not been investigated. The aims of the present study were to confirm the presence of dysexecutive cognitive syndrome (DCS) in adults with MMD and to explore the relationship of DCS with frontal lobe perfusion as measured by perfusion MR imaging.

Methods

Cerebral blood volume (CBV) ratio and mean transit time delay were measured in frontal and temporoparietal regions using the cerebellum as a reference region in 10 European adults with MMD. In addition, the authors calculated the cerebrovascular reserve (CVR) using the CBV ratio and the acetazolamide challenge. All patients underwent a standardized neuropsychological assessment test battery. The authors defined DCS as an impairment shown on 3 tests or more of executive function.

Results

The authors found DCS in 6 patients. The frontal CVR was lower in patients with DCS than in patients without DCS (mean ± SD: −13.5 ± 13.2% and 20.3 ± 21.3%; p = 0.019, Mann-Whitney U-test). Other parameters of frontal perfusion and temporoparietal CVR were not correlated with DCS.

Conclusions

The authors' findings suggest that DCS is common in European adults with MMD and may be related to frontal perfusion impairment.

Abbreviations used in this paper: CBF = cerebral blood flow; CBV = cerebral blood volume; CVR = cerebral vascular reserve; DCS = dysexecutive cognitive syndrome; ICA = internal carotid artery; MMD = moyamoya disease; MTT = mean transit time; rCBV = regional CBV; rCVR = regional CVR; rMTT = regional MTT; ROI = region of interest; TMTA = Trail Making Test, Part A; TMTB = TMT, Part B; WCST = Wisconsin Card Sorting Test.

Article Information

Address correspondence to: Lionel Calviere, M.D., Service de Neurologie Vasculaire du CHU Toulouse Rangueil, 1 Avenue Jean Poulhes, 31059 Toulouse Cedex, France. email: liocalviere@free.fr.

Please include this information when citing this paper: published online May 14, 2010; DOI: 10.3171/2010.4.JNS091808.

© AANS, except where prohibited by US copyright law.

Headings

References

1

Austin MPMitchell PGoodwin GM: Cognitive deficits in depression: possible implications for functional neuropathology. Br J Psychiatry 178:2002062001

2

Berthezene YNighoghossian NMeyer RDamien JCinotti LAdeleine P: Can cerebrovascular reactivity be assessed by dynamic susceptibility contrast-enhanced MRI?. Neuroradiology 40:151998

3

Bornstein RA: Neuropsychological performance in Moya Moya disease: a case study. Int J Neurosci 26:39461985

4

Braun CMJ: Evaluation Neuropsychologique MontréalÉditions Décarie1997

5

Calamante FGadian DGConnelly A: Delay and dispersion effects in dynamic susceptibility contrast MRI: simulations using singular value decomposition. Magn Reson Med 44:4664732000

6

Calamante FGadian DGConnelly A: Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke 33:114611512002

7

Calamante FGanesan VKirkham FJJan WChong WKGadian DG: MR perfusion imaging in Moyamoya Syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke 32:281028162001

8

Calviere LCatalaa IFrugier CGViguier AAlbucher JFDelisle MB: [Clinical course and outcome in French adults with Moyamoya disease.]. Rev Neurol (Paris) 165:7097192009. (Fr)

9

Cardebat DDoyon BPuel MGoulet PJoanette Y: [Formal and semantic lexical evocation in normal subjects. Performance and dynamics of production as a function of sex, age and educational level.]. Acta Neurol Belg 90:2072171990. (Fr)

10

Channon SGreen PS: Executive function in depression: the role of performance strategies in aiding depressed and non-depressed participants. J Neurol Neurosurg Psychiatry 66:1621711999

11

Derdeyn CPVideen TOYundt KDFritsch SMCarpenter DAGrubb RL: Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. Brain 125:5956072002

12

Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99:Suppl 2S238S2401997

13

Gibbs JMLeenders KLWise RJJones T: Evaluation of cerebral perfusion reserve in patients with carotid-artery occlusion. Lancet 1:1821861984

14

Godefroy OGrefex LMD: Fonctions Exécutives en Pathologies Neurologiques et Psychiatriques MarseilleSolal2008

15

Godefroy OJeannerod MAllain PLe Gall D: [Frontal lobe, executive functions and cognitive control.]. Rev Neurol (Paris) 164:Suppl 3S119S1272008. (Fr)

16

Godefroy ORoussel MLeclerc XLeys D: Deficit of episodic memory: anatomy and related patterns in stroke patients. Eur Neurol 61:2232292009

17

Grandin CBBol ASmith AMMichel CCosnard G: Absolute CBF and CBV measurements by MRI bolus tracking before and after acetazolamide challenge: repeatabilily and comparison with PET in humans. Neuroimage 26:5255352005

18

Hallemeier CLRich KMGrubb RL JrChicoine MRMoran CJCross DT III: Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 37:149014962006

19

Han DHNam DHOh CW: Moyamoya disease in adults: characteristics of clinical presentation and outcome after encephaloduro-arterio-synangiosis. Clin Neurol Neurosurg 99:Suppl 2S151S1551997

20

Hoare AMKeogh AJ: Cerebrovascular Moyamoya disease. BMJ 1:4304321974

21

Hoffman HJ: Moyamoya disease and syndrome. Clin Neurol Neurosurg 99:Suppl 2S39S441997

22

Honda MEzaki YKitagawa NTsutsumi KOgawa YNagata I: Quantification of the regional cerebral blood flow and vascular reserve in moyamoya disease using split-dose iodoamphetamine I 123 single-photon emission computed tomography. Surg Neurol 66:1551592006

23

Horn PLanczik OVajkoczy PDaffertshofer MBueltmann EWerner A: Hemodynamic reserve and high-intensity transient signals in moyamoya disease. Cerebrovasc Dis 19:1411462005

24

Imaizumi CImaizumi TOsawa MFukuyama YTakeshita M: Serial intelligence test scores in pediatric moyamoya disease. Neuropediatrics 30:2942991999

25

Jefferson ALGlosser GDetre JASinson GLiebeskind DS: Neuropsychological and perfusion MR imaging correlates of revascularization in a case of moyamoya syndrome. AJNR Am J Neuroradiol 27:981002006

26

Karzmark PZeifert PDTan SDorfman LJBell-Stephens TESteinberg GK: Effect of moyamoya disease on neuropsychological functioning in adults. Neurosurgery 62:104810522008

27

Kraemer MHeienbrok WBerlit P: Moyamoya disease in Europeans. Stroke 39:319332002008

28

Kuriyama SKusaka YFujimura MWakai KTamakoshi AHashimoto S: Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 39:42472008

29

Kuroda SHoukin KKamiyama HAbe HMitsumori K: Regional cerebral hemodynamics in childhood moyamoya disease. Childs Nerv Syst 11:5845901995

30

Kuwabara YIchiya YSasaki MYoshida TMasuda KIkezaki K: Cerebral hemodynamics and metabolism in moyamoya disease—a positron emission tomography study. Clin Neurol Neurosurg 99:Suppl 2S74S781997

31

Kuwabara YIchiya YSasaki MYoshida TMasuda KMatsushima T: Response to hypercapnia in moyamoya disease. Cerebrovascular response to hypercapnia in pediatric and adult patients with moyamoya disease. Stroke 28:7017071997

32

Lubman DIPantelis CDesmond PProffitt TMVelakoulis D: Moyamoya disease in a patient with schizophrenia. J Int Neuropsychol Soc 9:8068102003

33

Matsushima YAoyagi MMasaoka HSuzuki ROhno K: Mental outcome following encephaloduroarteriosynangiosis in children with moyamoya disease with the onset earlier than 5 years of age. Childs Nerv Syst 6:4404431990

34

Ogasawara KKomoribayashi NKobayashi MFukuda TInoue TYamadate K: Neural damage caused by cerebral hyperperfusion after arterial bypass surgery in a patient with moyamoya disease: case report. Neurosurgery 56:E13802005

35

Okazawa HYamauchi HSugimoto KToyoda HKishibe YTakahashi M: Effects of acetazolamide on cerebral blood flow, blood volume, and oxygen metabolism: a positron emission tomography study with healthy volunteers. J Cereb Blood Flow Metab 21:147214792001

36

Paulson OBStrandgaard SEdvinsson L: Cerebral autoregulation. Cerebrovasc Brain Metab Rev 2:1611921990

37

Rogg JRutigliano MYonas HJohnson DWPentheny SLatchaw RE: The acetazolamide challenge: imaging techniques designed to evaluate cerebral blood flow reserve. AJR Am J Roentgenol 153:6056121989

38

Rovira MTorrent ORuscalleda J: Etiology of moya moya disease acquired or congenital. Acta Radiol Suppl 347:2292401976

39

Steiger HJAaslid RStooss R: Dynamic computed tomographic imaging of regional cerebral blood flow and blood volume. A clinical pilot study. Stroke 24:5915971993

40

Strandgaard SPaulson OB: Cerebral autoregulation. Stroke 15:4134161984

41

Suzuki JKodama N: Moyamoya disease—a review. Stroke 14:1041091983

42

Suzuki JTakaku A: Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20:2882991969

43

Tanaka YNariai TNagaoka TAkimoto HIshiwata KIshii K: Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging—comparison with positron emission tomography. J Cereb Blood Flow Metab 26:2913002006

44

Tombaugh TN: Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol 19:2032142004

45

Van der Linden M: [Memory function in elderly persons.]. Rev Med Liege 48:4814991993. (Fr)

46

Vorstrup SHenriksen LPaulson OB: Effect of acetazolamide on cerebral blood flow and cerebral metabolic rate for oxygen. J Clin Invest 74:163416391984

47

Yonas HPindzola RRMeltzer CCSasser H: Qualitative versus quantitative assessment of cerebrovascular reserves. Neurosurgery 42:100510121998

48

Yun TJCheon JENa DGKim WSKim IOChang KH: Childhood moyamoya disease: quantitative evaluation of perfusion MR imaging—correlation with clinical outcome after revascularization surgery. Radiology 251:2162232009

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 70 70 41
Full Text Views 122 122 24
PDF Downloads 96 96 12
EPUB Downloads 0 0 0

PubMed

Google Scholar